Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Predicting dedifferentiation in liposarcoma: a proteomic approach.
[dedifferentiated liposarcoma]
There
are
no
known
morphologic
characteristics
,
cytogenetic
aberrations
,
or
molecular
alterations
predictive
of
dedifferentiation
in
liposarcomas
.
Identification
of
such
a
prognostic
marker
could
potentially
affect
surgical
and
adjuvant
therapy
and
/
or
follow-up
surveillance
for
these
patients
.
Two
-dimensional
difference
gel
electrophoresis
was
utilized
to
characterize
protein
expression
patterns
in
lipoma
,
atypical
lipomatous
tumor
(
ALT
)
,
and
the
well-differentiated
components
of
dedifferentiated
liposarcoma
(
DDL
)
.
Protein
spots
were
identified
by
peptide
mapping
/
fingerprinting
using
matrix-assisted
laser
desorption
ionization
time-of-flight
mass
spectrometry
.
No
significant
differences
in
protein
expression
were
identified
between
lipoma
and
ALT
or
DDL
.
Proteins
that
were
significantly
down-regulated
in
the
well-differentiated
component
of
DDL
compared
to
ALT
included
mitochondrial
aldehyde
dehydrogenase
2
(
ALDH
2
,
>
3
-
fold
reduction
)
and
selenium-binding
protein-
1
(
SELENBP
1
,
>
4
-
fold
reduction
)
.
Subsequent
validation
studies
were
performed
by
immunohistochemistry
(
IHC
)
on
a
separate
series
of
ALT
(
n
 
=
 
30
)
and
the
well-differentiated
components
of
DDL
(
n
 
=
 
28
)
.
IHC
stains
were
evaluated
in
a
semi-quantitative
manner
,
and
the
results
were
analyzed
using
the
Mann-
Whitney
test
and
receiver-operator
curve
analysis
.
Decreased
IHC
staining
for
SELENBP
1
in
the
well-differentiated
component
of
DDL
was
confirmed
.
Cytoplasmic
ALDH
2
levels
determined
by
IHC
were
not
significantly
different
in
ALT
and
DDL
;
no
nuclear
staining
for
ALDH
2
was
observed
.
Expression
of
SELENBP
1
is
decreased
in
the
well-differentiated
component
of
DDL
compared
to
ALT
.
However
,
variability
in
the
staining
patterns
in
liposarcoma
precludes
its
use
as
a
predictive
marker
for
dedifferentiation
.
Diseases
Validation
Diseases presenting
"known morphologic characteristics, cytogenetic aberrations"
symptom
dedifferentiated liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom